Japan Veterinary Healthcare Market Growth & Forecast [2031]

Segments - Japan Veterinary Healthcare Market by Products (Diagnostics [Immunodiagnostic Tests, Molecular Diagnostics, Diagnostic Imaging, Clinical Chemistry, Others] and Therapeutics [Parasiticides, Vaccines, Medical Feed Additives, Anti-infectives, and Others]), Types of Animals (Swine, Horses, Dogs and Cats, Ruminants, Poultry, and Others), and Country - Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031

Author : Raksha Sharma

Fact-checked by : Vineet Pandey

Editor : Vishal Golekar

Report Description

The Japan veterinary healthcare market size was valued at USD 2181.17 Million in 2022 and is projected to surpass USD 4360.17 Million by 2031, expanding at a CAGR of 8% during the forecast period, 2023–2031. The growth of the market is attributed to the increasing pet ownership.

Veterinary healthcare can be described as medical tests performed to protect the health and productivity of animals, as well as the early diagnosis and treatment of illness symptoms. The tests are carried out using a variety of techniques that include the use of blood, pee, stool, and biopsies from animals. Veterinary diagnosis is used to diagnose a wide spectrum of animals, both wild and domestic. The industry's expansion is being accelerated by new forms of animal diseases and their subsequent transmission to people through animal interaction and animal foodstuff use.

Japan Veterinary Healthcare Market Outlook

Veterinary medicine is defined as the science associated with the diagnosis, treatment, and prevention of diseases in animals. Besides, the increasing importance of the production of livestock animals is generating growth in the veterinary healthcare market. During the pandemic of Covid-19, In a poll performed by the Japan Pet Food Association in 2020, dog and cat ownership increased by 15% over the past year. As of October 2020, Japan had approximately 8 million dogs and 9 million cats maintained as pets.

Japan Veterinary Healthcare Market Trends, Drivers, Restraints, and Opportunities

Governmental agencies and the food industry are reforming to maintain health through monitoring and vaccinations are estimated to spur the market growth during the forecast period.
Spending in R&D and spreading research in the areas of veterinary healthcare are the main factors propelling the market expansion.
Technological advancement resulting in animal healthcare, as well as growing awareness well about the welfare of animals fed as foods, are anticipated to fuel the market growth.
Threat of zoonotic infections is driving the market growth.
Rising expenses of animal testing and veterinary care are estimated to impede the market expansion.
Using parasiticides in food-producing animals and the increasing maintenance costs of animal vaccinations are projected to hinder the market.

Scope of the Japan Veterinary Healthcare Market Report

The report on the Japan veterinary healthcare market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes	Details
Report Title	Japan Veterinary Healthcare Market - Industry Analysis, Growth, Share, Size, Trends, and Forecast
Base Year	2022
Historic Data	2016–2021
Forecast Period	2023–2031
Segmentation	Products (Diagnostics [Immunodiagnostic Tests, Molecular Diagnostics, Diagnostic Imaging, Clinical Chemistry, Others] and Therapeutics [Parasiticides, Vaccines, Medical Feed Additives, Anti-infectives, and Others]), and Types of Animals (Swine, Horses, Dogs and Cats, Ruminants, Poultry, and Others)
Geographic Zone	Japan
Report Coverage	Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
Key Players Covered in the Report	Zoetis Inc.; Virbac; Sumitomo Dainippon Pharma Co., Ltd; Nisseiken Co., Ltd.; NIPPON ZENYAKU KOGYO CO., LTD.; NIHON NOHYAKU CO.,LTD.; Merck & Co., Inc.; FUJIFILM Holdings Corporation; Kyoritsu Seiyaku Corporation (Carus Animal Health); Boehringer Ingelheim GmbH; and Elanco Animal Health Incorporated

Japan Veterinary Healthcare Market Segment Insights

Therapeutics segment is projected to constitute a major market share

Based on products, the Japan veterinary healthcare market is divided into diagnostics and therapeutics. The therapeutics segment is further segmented into parasiticides, vaccines, medical feed additives, anti-infectives, and others. The vaccines by therapeutics segment is expected to account for a key share of the market during the forecast period due to vaccine advancements, increased government, and organization spending, expanding consumption of animal protein, such as milk, meat, eggs, and seafood, and increasing companion animal healthcare costs.

In addition, Kyoritsu seiyaku Corporation offers Canivac KC-3 for canine adenovirus (type 2) infections, canine parainfluenza, and canine Bordetella disease, as well as Felivac 3 for feline viral rhinotracheitis, feline calicivirus disease, and feline panleukopenia prophylaxis. As a result, the segment's expansion will be aided by the simple availability of all such products.

For instance, the diagnostics segment is further divided into immunodiagnostic tests, molecular diagnostics, diagnostic imaging, clinical chemistry, others.

Japan Veterinary Healthcare Market Products

Dogs and cats segment is expected to grow at a significant pace

On the basis of types of animals, the market is segregated into swine, horses, dogs and cats, ruminants, poultry, and others. The dogs and cats segment is expected to hold a key share of the market in the coming years owing to pet care can keep growing in present value terms in 2021. After the breakout of COVID-19, there was a surge in demand for pet animals including dogs and cats, as people are seeking company and amusement while stuck at home.

Segments

The Japan veterinary healthcare market has been segmented based on

Products

Diagnostics
- Immunodiagnostic Tests
- Molecular Diagnostics
- Diagnostic Imaging
- Clinical Chemistry
- Others
Therapeutics
- Parasiticides
- Vaccines
- Medical Feed Additives
- Anti-infectives
- Others

Types of Animals

Swine
Horses
Dogs and Cats
Ruminants
Poultry
Others

Key Players

Zoetis Inc.
Virbac
Sumitomo Dainippon Pharma Co., Ltd
Nisseiken Co., Ltd.
NIPPON ZENYAKU KOGYO CO., LTD.
NIHON NOHYAKU CO.,LTD.
Merck & Co., Inc.
FUJIFILM Holdings Corporation
Kyoritsu Seiyaku Corporation (Carus Animal Health)
Boehringer Ingelheim GmbH
Elanco Animal Health Incorporated

Competitive Landscape

Key players competing in the Japan veterinary healthcare market are Zoetis Inc.; Virbac; Sumitomo Dainippon Pharma Co., Ltd; Nisseiken Co., Ltd.; NIPPON ZENYAKU KOGYO CO., LTD.; NIHON NOHYAKU CO.,LTD.; Merck & Co., Inc.; FUJIFILM Holdings Corporation; Kyoritsu Seiyaku Corporation (Carus Animal Health); Boehringer Ingelheim GmbH; and Elanco Animal Health Incorporated. Some of these players are adopting several business strategies such as acquisitions, mergers, collaborations, partnerships, capacity expansion, and product launches to enhance their market shares.

Japan Veterinary Healthcare Market Key Players

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Veterinary Healthcare Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Veterinary Healthcare Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Veterinary Healthcare Market - Supply Chain
  4.5. Global Veterinary Healthcare Market Forecast
     4.5.1. Veterinary Healthcare Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Veterinary Healthcare Market Size (000â€™ Units) and Y-o-Y Growth
     4.5.3. Veterinary Healthcare Market Absolute $ Opportunity
5. Global Veterinary Healthcare Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Veterinary Healthcare Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Veterinary Healthcare Demand Share Forecast, 2019-2026
6. North America Veterinary Healthcare Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Veterinary Healthcare Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Veterinary Healthcare Demand Share Forecast, 2019-2026
7. Latin America Veterinary Healthcare Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Veterinary Healthcare Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Veterinary Healthcare Demand Share Forecast, 2019-2026
8. Europe Veterinary Healthcare Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Veterinary Healthcare Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Veterinary Healthcare Demand Share Forecast, 2019-2026
9. Asia Pacific Veterinary Healthcare Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Veterinary Healthcare Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Veterinary Healthcare Demand Share Forecast, 2019-2026
10. Middle East & Africa Veterinary Healthcare Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Veterinary Healthcare Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Veterinary Healthcare Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Veterinary Healthcare Market: Market Share Analysis
  11.2. Veterinary Healthcare Distributors and Customers
  11.3. Veterinary Healthcare Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. Zoetis Inc.
     11.4.2. Virbac
     11.4.3. Sumitomo Dainippon Pharma Co., Ltd
     11.4.4. Nisseiken Co., Ltd.
     11.4.5. NIPPON ZENYAKU KOGYO CO., LTD.
     11.4.6. NIHON NOHYAKU CO.,LTD.